Skip to main content
Caplight Logo









Vena Vitals

Vena Vitals

Private
Irvine, CaliforniaHealthcare & Life Scienceshttps://www.venavitals.com/

Last Round

Seed

Jul 1, 2025

Est. Valuation

$1.79M

Total Funding Raised

$3.12M

Company Overview

Vena Vitals is a medical technology company that develops a wearable, flexible sensor for continuous, non-invasive blood pressure monitoring.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Sensors, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

continuous blood pressure monitoringwearable sensornon-invasive blood pressurecuffless blood pressuremedical deviceremote patient monitoringRPMhealth IoTsignal processingclinical monitoringwearable health techdigital healthsleep apnea monitoringacute care monitoringmedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Vena Vitals Comparables

Compare Vena Vitals with similar companies based on industry and business-model similarity.

Vena Vitals comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
PyrAmes, Inc.
86%
Caretaker Medical
83%
Softsonics LLC
82%

Vena Vitals Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 1, 2025
SeedAug 24, 2023
GrantMar 15, 2023
SeedAug 29, 2022
GrantFeb 9, 2021
Grant
Sep 30, 2020

Key People

Founding team and executive leadership

Josh Kim

CTO Co-Founder

Founding Team

Vena Vitals Investors

Notable investors and investment history

Vena Vitals investors
InvestorRounds
Morado VenturesAccelerator, Seed
Pi CampusVC Round
MedTech InnovatorAccelerator, Grant
TK & PartnersSeed
Sunstone ManagementSeed
Samsung Next TLVAccelerator
Y CombinatorVC Round, Accelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 15, 2023

    $1M grant from the National Science Foundation

  • Feb 15, 2021

    $256K raised from the National Science Foundation.

Vena Vitals Filings

Explore SEC and related filing metadata, where available.

Vena Vitals filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Vena Vitals's valuation, stock price, and market status.

Is Vena Vitals a public or private company?

Vena Vitals is a private company.

What is the current stock price of Vena Vitals?

Vena Vitals is a private company with no public stock price. No recent secondary market data is available.

How much is Vena Vitals worth (valuation)?

Vena Vitals's valuation is estimated at $1.8M based on funding round data.

Can I buy Vena Vitals stock?

Vena Vitals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Vena Vitals's last funding round?

Vena Vitals's most recent funding round was Grant on August 25, 2020.

Who are the main investors in Vena Vitals?

Key investors in Vena Vitals include Sunstone Management, Y Combinator, National Science Foundation.

Will Vena Vitals IPO soon?

No public IPO plans have been announced for Vena Vitals.

How can I track Vena Vitals secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Vena Vitals's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersIrvine, California
Employee Range16
Year Founded2019
Last FundingJul 1, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?